Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-20-013865
Filing Date
2020-11-16
Accepted
2020-11-16 07:20:31
Documents
108
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q jagx-20200930x10q.htm 10-Q 2913038
2 EX-10.4 jagx-20200930ex104d7a47b.htm EX-10.4 406387
3 EX-10.5 jagx-20200930ex105d6e75f.htm EX-10.5 30408
4 EX-10.6 jagx-20200930ex106bb794e.htm EX-10.6 231128
5 EX-31.1 jagx-20200930ex311704183.htm EX-31.1 11019
6 EX-31.2 jagx-20200930ex312739530.htm EX-31.2 11018
7 EX-32.1 jagx-20200930ex3210d831a.htm EX-32.1 6965
8 EX-32.2 jagx-20200930ex322bdf521.htm EX-32.2 6940
9 GRAPHIC jagx-20200930ex104d7a47b001.jpg GRAPHIC 67354
10 GRAPHIC jagx-20200930ex104d7a47b002.jpg GRAPHIC 127119
11 GRAPHIC jagx-20200930ex104d7a47b003.jpg GRAPHIC 117106
  Complete submission text file 0001558370-20-013865.txt   16102602

Data Files

Seq Description Document Type Size
12 EX-101.INS jagx-20200930.xml EX-101.INS 2789503
13 EX-101.SCH jagx-20200930.xsd EX-101.SCH 155662
14 EX-101.CAL jagx-20200930_cal.xml EX-101.CAL 64169
15 EX-101.DEF jagx-20200930_def.xml EX-101.DEF 777092
16 EX-101.LAB jagx-20200930_lab.xml EX-101.LAB 1068352
17 EX-101.PRE jagx-20200930_pre.xml EX-101.PRE 1006412
Mailing Address 200 PINE STREET SUITE 400 SAN FRANCISCO CA 94104
Business Address 200 PINE STREET SUITE 400 SAN FRANCISCO CA 94104 415-371-8300
Jaguar Health, Inc. (Filer) CIK: 0001585608 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36714 | Film No.: 201313659
SIC: 2834 Pharmaceutical Preparations